Mary Linton B Peters, MD, MS

Beth Israel Deaconess Medical Center

Academic Titles

Assistant Professor, Medicine, Harvard Medical School

Research Program Affiliation

Member, Gastrointestinal Malignancies

Research Abstract

My initial academic and professional experience was in decision analysis and disease modeling, first at Stanford and then at Strategic Decisions Group. In recognition of this expertise, I was elected Fellow of the Society of Decision Professionals. As part of my medical training, I have gained experience in clinical research and health outcomes modeling, including dedicated research training during medical school and residency, and Harvard Catalyst courses in biostatistics and grant writing. I was selected to attend the AACR/ASCO Methods in Clinical Cancer Research workshop, developing a Phase 2 protocol in cholangiocarcinoma. I have been working with MGH’s Institute for Technology Assessment (ITA) since 2015. Mentored by Dr Pari Pandharipande, the Director of the ITA, we have developed a model of MRI screening strategies for first-degree family members of pancreatic ductal adenocarcinoma (PDAC) patients, the basis for my current research into the cost-effectiveness of germline genetic testing in this disease. In March 2020 I was awarded a K08 to support this work. Upon completion of fellowship in June 2017, I joined the faculty at BIDMC in the Medical Oncology division, with a clinical focus in GI Oncology and specifically hepatobiliary and pancreatic malignancies. In early 2020 I was promoted to Assistant Professor and became a senior scientist at the ITA. I am DF/HCC lead PI for 4 clinical trials and Site PI for 12 clinical trials largely in hepatobiliary cancers.